Literature DB >> 1437436

Systemic infections due to Streptococcus pneumoniae relatively resistant to penicillin in a children's hospital: clinical management and outcome.

T Q Tan1, E O Mason, S L Kaplan.   

Abstract

Streptococcus pneumoniae isolates relatively (0.1 microgram/mL < minimum inhibitory concentration < or = 1.0 microgram/mL) resistant to penicillin (RRP) have been recovered worldwide, but reports of therapy and outcome of systemic infections due to these strains are limited. This retrospective study of prospectively identified patients reviews the clinical features, management, and outcome of 19 children with systemic infections due to S pneumoniae. From January 1, 1989 to December 31, 1991, 13 of 244 blood (5.3%) and 4 of 32 cerebrospinal fluid (12.5%) pneumococcal isolates were relatively resistant to penicillin. The serotypes were as follows: 14 (12 isolates), 6 (4 isolates), 19 (2 isolates), 23 (1 isolates). One peritoneal fluid isolate and one joint fluid isolate were also relatively resistant to penicillin. The mean age of the 19 patients was 30 months (range 5 to 104 months), and five children had underlying disorders. Eleven children (nine inpatients) were treated initially with a parenteral cephalosporin. Six patients were treated as outpatients, and all had (occult) bacteremia. Three of these patients received ceftriaxone intramuscularly in the emergency department; five were treated with amoxicillin/clavulanic acid, and one received amoxicillin. Seven of 13 children treated in the hospital became afebrile in 48 hours. Three others were afebrile from the time of admission. Repeat blood cultures obtained within 24 to 48 hours after therapy was initiated were sterile in 10 children. All but one child responded to initial therapy. The recovery of S pneumoniae isolates relatively resistant to penicillin has increased in our hospital during the last 3 years.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1437436

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  8 in total

1.  Reduced susceptibility to penicillin among pneumococci causing invasive infection in children - Canada, 1991 to 1998.

Authors:  D Scheifele; S Halperin; L Pelletier; J Talbot; M Lovgren; W Vaudry; T Jadavji; B Law; N Macdonald; R Gold; E Wang; E Mills; M Lebel; P Déry; R Morris
Journal:  Can J Infect Dis       Date:  2001-07

2.  In vitro activities of oxazolidinones U-100592 and U-100766 against penicillin-resistant and cephalosporin-resistant strains of Streptococcus pneumoniae.

Authors:  E O Mason; L B Lamberth; S L Kaplan
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

3.  Evaluation of commercial methods for determining antimicrobial susceptibility of Streptococcus pneumoniae.

Authors:  F C Tenover; C N Baker; J M Swenson
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

Review 4.  Antibiotic resistant Streptococcus pneumoniae.

Authors:  E J Minton; J T Macfarlane
Journal:  Thorax       Date:  1996-08       Impact factor: 9.139

5.  Cefotaxime breakpoint for Streptococcus pneumoniae.

Authors:  E Cantón
Journal:  Antimicrob Agents Chemother       Date:  1993-03       Impact factor: 5.191

6.  Penicillin resistant pneumococcal infection--a serious concern for India.

Authors:  M Hiranandani; I Kaur
Journal:  Indian J Pediatr       Date:  1994 May-Jun       Impact factor: 1.967

Review 7.  Management of infections due to antibiotic-resistant Streptococcus pneumoniae.

Authors:  S L Kaplan; E O Mason
Journal:  Clin Microbiol Rev       Date:  1998-10       Impact factor: 26.132

8.  Antibiotic therapy and acute outcome of meningitis due to Streptococcus pneumoniae considered intermediately susceptible to broad-spectrum cephalosporins.

Authors:  T Q Tan; G E Schutze; E O Mason; S L Kaplan
Journal:  Antimicrob Agents Chemother       Date:  1994-05       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.